Cargando…
Second Primary Malignancies and Myeloma Therapy: Fad or Fact?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660058/ https://www.ncbi.nlm.nih.gov/pubmed/22989934 |
| _version_ | 1782270502465699840 |
|---|---|
| author | Usmani, Saad Z. |
| author_facet | Usmani, Saad Z. |
| author_sort | Usmani, Saad Z. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3660058 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-36600582013-05-21 Second Primary Malignancies and Myeloma Therapy: Fad or Fact? Usmani, Saad Z. Oncotarget Editorial Impact Journals LLC 2012-09-15 /pmc/articles/PMC3660058/ /pubmed/22989934 Text en Copyright: © 2012 Usmani http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited |
| spellingShingle | Editorial Usmani, Saad Z. Second Primary Malignancies and Myeloma Therapy: Fad or Fact? |
| title | Second Primary Malignancies and Myeloma Therapy: Fad or Fact? |
| title_full | Second Primary Malignancies and Myeloma Therapy: Fad or Fact? |
| title_fullStr | Second Primary Malignancies and Myeloma Therapy: Fad or Fact? |
| title_full_unstemmed | Second Primary Malignancies and Myeloma Therapy: Fad or Fact? |
| title_short | Second Primary Malignancies and Myeloma Therapy: Fad or Fact? |
| title_sort | second primary malignancies and myeloma therapy: fad or fact? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660058/ https://www.ncbi.nlm.nih.gov/pubmed/22989934 |
| work_keys_str_mv | AT usmanisaadz secondprimarymalignanciesandmyelomatherapyfadorfact |